Oxyntomodulin augments glucose homeostasis

March 21, 2018

(HealthDay)—In obese subjects with and without type 2 diabetes mellitus (T2DM), oxyntomodulin (OXM) significantly augments glucose-dependent insulin secretion, according to a study published online March 15 in Diabetes.

Sudha S. Shankar, M.D., from Merck & Co. Inc. in Kenilworth, N.J., and colleagues examined the effects of OXM on glucose homeostasis. The effects of an intravenous infusion of native OXM on insulin secretory rates (ISR) and glycemic excursion were assessed in a graded glucose infusion (GGI) procedure in two separate placebo-controlled trials in 12 overweight and obese subjects without and in 12 obese subjects with T2DM. The glucagon-like peptide-1 (GLP-1) analog liraglutide was a comparator in the T2DM trial.

The researchers found that in the GGI, 3.0 pmol/kg/min of OXM significantly increased ISR in both groups and blunted glycemic excursion relative to placebo. The effects of OXM were comparable to those of liraglutide among individuals with T2DM, including the restoration of beta cell glucose responsiveness to that of non-obese subjects without diabetes.

"Our findings indicate that native OXM significantly augments glucose-dependent insulin secretion acutely in obese subjects with and without diabetes, with effects comparable to pharmacologic GLP-1 receptor activation and independent of ," the authors write. "Native OXM has potential to improve hyperglycemia via complementary and independent induction of secretion and weight loss."

Several authors disclosed financial ties to Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc.

Explore further: Beta-cell sensitivity to glucose impaired after gastric bypass

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Beta-cell sensitivity to glucose impaired after gastric bypass

December 11, 2017
(HealthDay)—Individuals with prior Roux-en-Y gastric bypass (GB) have blunted β-cell sensitivity to changes in glycemia, according to a study published online Nov. 20 in Diabetes, Obesity and Metabolism.

DPP-4 inhibitor has dissociated effects on β-cell function

December 20, 2017
(HealthDay)—For healthy adults and individuals with well-controlled type 2 diabetes (T2D), a single dose of the dipeptidyl peptidase-4 inhibitor sitagliptin is associated with increased standardized insulin secretion, with ...

Brain glucose responses diminish with diabetes, obesity

November 20, 2017
(HealthDay)—The rise of brain glucose levels is blunted during hyperglycemia in adults with obesity and type 2 diabetes mellitus (T2DM), according to a study published online Oct. 19 in JCI Insight.

Absolute incretin effect reduced in type 2 diabetes

June 25, 2012
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) the absolute incretin effect is reduced compared with healthy individuals, but its relative importance is increased, particularly in first-phase insulin secretion, ...

Pre-op liraglutide cuts post-op plasma glucose in T2DM

December 19, 2017
(HealthDay)—For patients with type 2 diabetes mellitus undergoing non-cardiac surgery, premedication with liraglutide is associated with reduced median plasma glucose one hour postoperatively, according to a study published ...

Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017
(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), ...

Recommended for you

Night shifts and unhealthy lifestyle linked to particularly high risk of type 2 diabetes

November 21, 2018
Women who work intermittent night shifts and do not follow a healthy lifestyle face an especially high risk of type 2 diabetes, suggests a study published by The BMJ today.

Gut protein mutations shield against spikes in glucose

November 20, 2018
Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

Can't exercise? A hot bath may help improve inflammation, metabolism, study suggests

November 14, 2018
Hot water treatment may help improve inflammation and blood sugar (glucose) levels in people who are unable to exercise, according to a new study. The findings are published ahead of print in the Journal of Applied Physiology.

Diabetic foot ulcers heal quickly with nitric oxide technology

November 12, 2018
Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.

Diabetes drug might also ease heart failure risks

November 12, 2018
(HealthDay)—The diabetes drug Farxiga might do double-duty for patients, helping to ward off another killer, heart failure, new research shows.

Marijuana use tied to serious diabetes complication

November 8, 2018
(HealthDay)—People with type 1 diabetes who use marijuana may double their risk of developing a life-threatening complication, a new study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.